Li Ka-shing, a renowned Hong Kong billionaire and philanthropist, demonstrated leadership in early diagnostics by strategically investing in AI healthcare startups. These investments contributed to advancements in diagnostics and personalized medicine, showcasing his commitment to improving healthcare. Li Ka-shing's support has been pivotal in driving innovation in this critical sector.